Richard De Schutter elected chair of Durata
This article was originally published in Scrip
Executive Summary
Durata Therapeutics has elected Richard DeSchutter chair of the company's board of directors. Mr De Schutter is also chair of Incyte Corporation, and was previously chair and CEO of DuPont Pharmaceuticals.